Search details
1.
Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3-decade retrospective review.
Haemophilia
; 28(1): 151-157, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34730853
2.
Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
Haemophilia
; 28(6): e228-e236, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35877992
3.
Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
Haemophilia
; 28(6): 977-985, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35768896
4.
Risk of diabetes in haemophilia patients compared to clinic and non-clinic control cohorts.
Haemophilia
; 28(3): 445-452, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35238443
5.
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes.
Haemophilia
; 27(5): 751-759, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34160870
6.
Erectile dysfunction in patients with haemophilia.
Haemophilia
; 25(2): 283-288, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30817087
7.
Vocational experiences and career support opportunities among Canadian men with moderate and severe haemophilia.
Haemophilia
; 25(3): 441-446, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30817061
8.
Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers.
Haemophilia
; 25(2): 296-305, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30817086
9.
Patient-centred care in haemophilia: Patient perspectives on visualization and participation in decision-making.
Haemophilia
; 25(6): 938-945, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31531924
10.
Desmopressin in moderate hemophilia A patients: a treatment worth considering.
Haematologica
; 103(3): 550-557, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29305412
11.
Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A.
Haemophilia
; 23(6): 877-883, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28851133
12.
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
Br J Haematol
; 168(1): 124-34, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25208598
13.
Treatment changes in hemophilia A with chromogenic factor VIII assay implementation.
Res Pract Thromb Haemost
; 7(2): 100098, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-37063773
14.
Physician Assistant School Applicants' Perceptions of Virtual Interviews.
J Allied Health
; 52(2): e47-e53, 2023.
Article
in English
| MEDLINE | ID: mdl-37269037
15.
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.
J Thromb Haemost
; 21(4): 850-861, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36696222
16.
Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world setting.
Res Pract Thromb Haemost
; 6(6): e12777, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-36090159
17.
Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells.
Infect Immun
; 79(10): 3887-94, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21825064
18.
The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation.
Blood
; 113(14): 3348-51, 2009 Apr 02.
Article
in English
| MEDLINE | ID: mdl-19060241
19.
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.
Res Pract Thromb Haemost
; 5(7): e12601, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34667922
20.
A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects.
Thromb Haemost
; 121(10): 1326-1336, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33506480